Céline Auzanneau

838 total citations
20 papers, 499 citations indexed

About

Céline Auzanneau is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Céline Auzanneau has authored 20 papers receiving a total of 499 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 8 papers in Oncology and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Céline Auzanneau's work include Ion channel regulation and function (3 papers), Cancer Genomics and Diagnostics (3 papers) and DNA Repair Mechanisms (2 papers). Céline Auzanneau is often cited by papers focused on Ion channel regulation and function (3 papers), Cancer Genomics and Diagnostics (3 papers) and DNA Repair Mechanisms (2 papers). Céline Auzanneau collaborates with scholars based in France, United Kingdom and United States. Céline Auzanneau's co-authors include Frédéric Becq, Vincent Thoreau, Alain Kitzis, Olivier Devuyst, Pierre J. Courtoy, Isabelle Soubeyran, François Jouret, Antoîne Italiano, Carlos Gomez‐Roca and Sophie Cousin and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Cancer Research.

In The Last Decade

Céline Auzanneau

19 papers receiving 491 citations

Peers

Céline Auzanneau

ONCOL

PRM

PFM

SURGE

Francesca Saccani Italy

F. Sala Italy

Qingqing He China

Giacomo Canesin United States

Ching-Shyang Chen Taiwan

Chengzhi Xie China

Gang Hu China

Bo Mu China

Jiansha Li China

David Ordaz‐Rosado Mexico

Francesca Saccani Italy

Céline Auzanneau

212 ×0.9

159 ×0.8

ONCOL

101 ×1.3

PRM

33 ×0.4

PFM

35 ×0.6

SURGE

Citations per year, relative to Céline Auzanneau Céline Auzanneau (= 1×) peers Francesca Saccani

Countries citing papers authored by Céline Auzanneau

Since Specialization

Citations

This map shows the geographic impact of Céline Auzanneau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Céline Auzanneau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Céline Auzanneau more than expected).

Fields of papers citing papers by Céline Auzanneau

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Céline Auzanneau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Céline Auzanneau. The network helps show where Céline Auzanneau may publish in the future.

Co-authorship network of co-authors of Céline Auzanneau

This figure shows the co-authorship network connecting the top 25 collaborators of Céline Auzanneau. A scholar is included among the top collaborators of Céline Auzanneau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Céline Auzanneau. Céline Auzanneau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Toulmonde, Maud, Mariella Spalato Ceruso, François Bertucci, et al.. (2023). PEMBROCABOSARC: Combination of pembrolizumab and cabozantinib in patients with advanced sarcomas.. Journal of Clinical Oncology. 41(16_suppl). TPS11586–TPS11586. 1 indexed citations

Albert, Sabrina, Antoine Italiano, Maud Toulmonde, et al.. (2022). 1525TiP TORNADO: A randomized multicenter open-label phase II study evaluating retifanlimab in combination with neoadjuvant chemotherapy in patients with selected retroperitoneal sarcomas. Annals of Oncology. 33. S1242–S1243.

Cousin, Sophie, Coralie Cantarel, Jean‐Philippe Guégan, et al.. (2022). Regorafenib–avelumab combination in patients with biliary tract cancer (REGOMUNE): a single-arm, open-label, phase II trial. European Journal of Cancer. 162. 161–169. 35 indexed citations

Italiano, Antoîne, Nicolás Isambert, Jean‐Philippe Metges, et al.. (2022). CAIRE: A basket multicenter open-label phase 2 study evaluating the EZH2 inhibitor tazemetostat in combination with durvalumab in patients with advanced solid tumors.. Journal of Clinical Oncology. 40(16_suppl). TPS2703–TPS2703. 4 indexed citations

Cousin, Sophie, Coralie Cantarel, Jean‐Philippe Guégan, et al.. (2021). Regorafenib-Avelumab Combination in Patients with Microsatellite Stable Colorectal Cancer (REGOMUNE): A Single-arm, Open-label, Phase II Trial. Clinical Cancer Research. 27(8). 2139–2147. 95 indexed citations

Morvan, Valérie Le, Élodie Richard, Delphine Fessart, et al.. (2020). Cytochrome P450 1B1 polymorphism drives cancer cell stemness and patient outcome in head-and-neck carcinoma. British Journal of Cancer. 123(5). 772–784. 12 indexed citations

Grellety, Thomas, Carlo Lucchesi, Isabelle Hostein, et al.. (2017). High-depth sequencing of paired primary and metastatic tumours: Implications for personalised medicine. European Journal of Cancer. 84. 250–256. 6 indexed citations

Lartigue, Lydia, Jean Guillon, Céline Auzanneau, et al.. (2013). Antitumor activity of semisynthetic derivatives of Aconitum alkaloids. Investigational New Drugs. 32(1). 60–67. 6 indexed citations

Auzanneau, Céline, Valérie Le Morvan, Nadine Leygue, et al.. (2013). A functionalized heterobimetallic^99mTc/Re complex as a potential dual-modality imaging probe: synthesis, photophysical properties, cytotoxicity and cellular imaging investigations. Dalton Transactions. 43(2). 439–450. 26 indexed citations

10.

Morvan, Valérie Le, et al.. (2013). Abstract 2200: Relationship between cytochrome P450 1B1 (CYP1B1) and head and neck cancer cells proliferation, dissemination and chemosensitivity to anticancer drugs.. Cancer Research. 73(8_Supplement). 2200–2200. 2 indexed citations

11.

Laroche‐Clary, Audrey, Céline Auzanneau, Nicolas Ricard, et al.. (2012). Deciphering the role of the ERCC2 gene polymorphism on anticancer drug sensitivity. Carcinogenesis. 33(5). 962–968. 12 indexed citations

12.

Auzanneau, Céline, Danièle Montaudon, Rémi Jacquet, et al.. (2012). The Polyphenolic Ellagitannin Vescalagin Acts As a Preferential Catalytic Inhibitor of the α Isoform of Human DNA Topoisomerase II. Molecular Pharmacology. 82(1). 134–141. 30 indexed citations

13.

Gongora, Céline, Nadia Vezzio-Vié, Sandie Tuduri, et al.. (2011). New Topoisomerase I mutations are associated with resistance to camptothecin. Molecular Cancer. 10(1). 64–64. 56 indexed citations

14.

Auzanneau, Céline, Caroline Norez, Fabrice Antigny, et al.. (2007). Transient receptor potential vanilloid 1 (TRPV1) channels in cultured rat Sertoli cells regulate an acid sensing chloride channel. Biochemical Pharmacology. 75(2). 476–483. 21 indexed citations

15.

Auzanneau, Céline, et al.. (2006). Pharmacological profile of inhibition of the chloride channels activated by extracellular acid in cultured rat Sertoli cells. annales de biologie animale biochimie biophysique. 46(3). 241–255. 13 indexed citations

16.

Jouret, François, et al.. (2005). Ubiquitous and kidney-specific subunits of the vacuolar H+-ATPase are differentially expressed during nephrogenesis. Nephrology Dialysis Transplantation. 20. 3 indexed citations

17.

Auzanneau, Céline, Huguette Debaix, Étienne Marbaix, et al.. (2005). Ubiquitous and Kidney-Specific Subunits of Vacuolar H+-ATPase Are Differentially Expressed during Nephrogenesis. Journal of the American Society of Nephrology. 16(11). 3235–3246. 36 indexed citations

18.

Devuyst, Olivier, François Jouret, Céline Auzanneau, & Pierre J. Courtoy. (2005). Chloride Channels and Endocytosis: New Insights from Dent’s Disease and ClC-5 Knockout Mice. Nephron Physiology. 99(3). p69–p73. 36 indexed citations

19.

Norez, Caroline, Ghanshyam D. Heda, Timothy J. Jensen, et al.. (2004). Determination of CFTR chloride channel activity and pharmacology using radiotracer flux methods. Journal of Cystic Fibrosis. 3. 119–121. 45 indexed citations

20.

Auzanneau, Céline, Vincent Thoreau, Alain Kitzis, & Frédéric Becq. (2003). A Novel Voltage-dependent Chloride Current Activated by Extracellular Acidic pH in Cultured Rat Sertoli Cells. Journal of Biological Chemistry. 278(21). 19230–19236. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact